Related Experiment Video
Updated: Sep 16, 2025

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
Published on: October 13, 2023
Insights into Patient Heterogeneity in Sjögren's Disease
Lisa Pecorelli1, Kerstin Klein1,2
1Department of Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, 3008 Bern, Switzerland.
Patient stratification is crucial for Sjögren
Area of Science:
- Rheumatology
- Immunology
- Autoimmune Diseases
Background:
- Sjögren's disease (SjD) is a complex autoimmune disorder affecting multiple systems.
- Key symptoms include mucosal dryness, fatigue, and pain.
- Patient heterogeneity complicates diagnosis, treatment, and clinical trials.
Purpose of the Study:
- To review current patient stratification approaches for Sjögren's disease.
- To highlight the need for improved methods to manage SjD.
- To inform the development of targeted therapies.
Main Methods:
- Review of existing literature on Sjögren's disease patient stratification.
- Analysis of two primary stratification strategies: symptom-based and molecular-based.
- Examination of clinical and biological data within identified patient clusters.
Main Results:
- Two main stratification approaches are currently employed: symptom-based and molecular-based.
- Symptom-based stratification analyzes patient-reported outcomes and clinical/biological data.
- Molecular-based stratification uses molecular profiles to identify subgroups, followed by clinical analysis.
Conclusions:
- Combining stratification approaches offers significant potential for recognizing SjD subgroups.
- This integration can facilitate the development of personalized treatment strategies.
- Current research suggests 3-4 SjD patient subgroups exist, but their nature (stages vs. endotypes) requires further investigation.
More Related Videos
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome II : Assessment and Medical Management
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Nephrotic Syndrome I : Introduction
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...

